High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia

Abstract Background Acute myeloid leukemia (AML) is a highly heterogeneous malignancy with various outcomes, and therefore needs better risk stratification tools to help select optimal therapeutic options. Methods In this study, we identify miRNAs that could predict clinical outcome in a heterogeneo...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Huihui Zhang, Ninghan Zhang, Rong Wang, Tingting Shao, Yuan Feng, Yao Yao, Qingyun Wu, Shengyun Zhu, Jiang Cao, Huanxin Zhang, Zhenyu Li, Xuejiao Liu, Mingshan Niu, Kailin Xu
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2019-04-01
Sarja:	Journal of Translational Medicine
Aiheet:	Mir-363 Acute myeloid leukemia Clinical outcome Chemotherapy Allo-HSCT
Linkit:	http://link.springer.com/article/10.1186/s12967-019-1858-7
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!